Ethical data practices and the importance of informed consent

Ethical data practices and the importance of informed consent

By Sofie Krabbe,

Partisia Platform, Confidential Computing, My Data Activation, Informed Consent

Recently, there has been extensive media coverage in Denmark about a significant research project involving health data.

Info

In Denmark, every newborn undergoes a "heel test" – a blood sample taken from the heel to detect rare but serious diseases. Early detection allows for effective treatment. The samples are sent to an institute for analysis and storage.

In a close collaboration Partisia and the Data for Good foundation aims to change the way we’re working with sensitive information, in an encrypted and secure way, where the individual has full transparency and control of how their data is being used. All usage and sharing of data must only be done after explicit consent, through a platform where the user can do this easily.

For Partisia and the Data for Good foundation, this agenda is highly relevant. 

no alt text
We are working together on developing a platform that balances privacy, transparency and auditability by combining Multiparty Computation and Distributed Ledger technology. This means that we create auditable tamper proof consent logs and only the analysis results are revealed and never the personal information. In other words only the results are revealed and never the personal information
Kim Nørskov Chief Success Officer, Partisia

The importance of Informed Consent

The collection and analysis of data have always been essential for progress and innovation. This allows individuals to make decisions based on the most informed basis, especially in fields such as the health industry. Data is a critical asset driving the development of new medicines and understanding of e.g. side effects.

In today's digital age, how we collect, utilise, and store data has become more important than ever, raising ethical concerns that were previously less significant. Therefore, the importance of informed consent and establishing proper frameworks and platforms to protect data while ensuring precise consent is paramount.

Informed consent is crucial, especially considering the meaning of "informed." It ensures that the person giving consent fully understands how their data will be used, in a completely transparent manner.

The controversy surrounding the usage of blood samples highlights the critical need for informed consent in research involving sensitive genetic data. Using personal genetic information without explicit consent undermines trust in medical research and violates individuals' privacy rights. This in the end means that we are more reluctant to share our data, also when it can be for the public good and better services.

Partisia addresses these challenges by providing solutions that ensure secure data sharing through advanced encryption and privacy-preserving technologies. The Partisia Confidential Computing platform uses Multiparty Computation (MPC) to allow researchers to analyse sensitive datasets without compromising individual privacy. This way we can get the best of both worlds: None of us needs to reveal private data, but we can still produce the data driven insights.

Additionally, My Data Activation facilitates precise consent for patients to use their health data, ensuring compliance and transparency and most importantly trust.

By leveraging State-of-the-art technologies, Partisia and DfG ensures that sensitive data is handled responsibly, building public trust and upholding privacy rights. What we at Partisia provide with technology, DfG matches with its neutral ‘good governance model’.

In short, both informed consent and the technologies developed by Partisia play crucial roles in ensuring ethical standards, enhancing privacy and security, and fostering trust in medical, research, and digital environments.

At Partisia we have spent more than a decade researching and developing a product that empowers individuals as citizens, patients and customers and facilitates a new way for activating sensitive and personal data. Read more about our My Data Activation.

Read more about our partners at Data for Good.

no alt text

IPsych - genetic data project

The media spotlight is on the IPsych project, which aims to look for causes and treatments of psychiatric conditions such as ADHD, autism, schizophrenia, depression, and bipolar disorder. This project includes genetic data from individuals born in Denmark between May 1, 1981, and December 31, 2008. 

Consequently, over two million Danes may have their genetic information included in this research.

The collected genetic data is combined with various personal information, including health, family history of mental or physical illness, social and economic conditions, education, employment, and more. Participants are not informed that their data is included in the project.

Different legislations since 2012

When IPsych began in 2012, the laws regarding the handling of sensitive personal information, such as genetic data, were different, and the project operated within legal boundaries. However, today's regulations on personal data collection and consent are much stricter. According to the National Scientific Ethics Committee, which oversees genetic data research and protects test subjects' interests, the IPsych project would not be approved under current laws.

In 2021, the committee declined to extend IPsych's permit, citing ethical concerns. They stated that the project would not meet today's legislative, guideline, and practice standards.

Get in touch

Kim Nørskov

Kim Nørskov

Chief Success Officer

kim.norskov@partisia.com

Who is Partisia?

We are an innovative software company and a trusted partner empowering companies to compute on encrypted data. Providing a platform where data from individuals, governments and private companies are able to stay encrypted and protected, and still fully enabled. Partisia is founded by pioneers within Multiparty Computation and advanced cryptography.